Cellectis S.A. Files February 2025 6-K Report
Ticker: CLLS · Form: 6-K · Filed: Feb 24, 2025 · CIK: 1627281
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Cellectis filed its monthly 6-K, confirming its foreign private issuer status and 20-F reporting.
AI Summary
Cellectis S.A. filed a Form 6-K on February 24, 2025, for the month of February 2025. The filing indicates that Cellectis is a foreign private issuer and files annual reports under Form 20-F. The company's principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Cellectis S.A.'s status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material financial or operational information.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- 8, rue de la Croix Jarry, 75013 Paris, France (location) — Principal executive office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer would be required to make public pursuant to the laws of its home country, or to file with and make public by any stock exchange on which its securities are traded.
What is Cellectis S.A.'s filing status?
Cellectis S.A. is a foreign private issuer and files annual reports under cover of Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on February 24, 2025.
What period does this Form 6-K cover?
This Form 6-K is for the month of February 2025.
Where is Cellectis S.A.'s principal executive office located?
Cellectis S.A.'s principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 24, 2025 regarding Cellectis S.A. (CLLS).